Newsletter
Low- vs High-Intensity Walking for PAD, Celecoxib for Stage III CRC, N95 Reprocessing Review, and more

JAMA Editor’s Summary

Low- vs High-Intensity Walking for PAD, Celecoxib for Stage III CRC, N95 Reprocessing Review, and more

Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the
April 6, 2021

Low- vs High-Intensity Walking for PAD, Celecoxib for Stage III CRC, N95 Reprocessing Review, and more

Editor’s Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the April 6, 2021 issue

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
Four Authors Untangle When Dad Has Dementia Virtual Q&A on the changes and challenges a dementia diagnosis.